Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03034356
PHASE1/PHASE2
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Sponsor: VA Office of Research and Development
View on ClinicalTrials.gov
Summary
This study plans to learn more about the effects of levetiracetam (LEV) on brain activity and cognition in schizophrenia and schizoaffective disorder. Levetiracetam is an anti-seizure drug, also called an anticonvulsant.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
67
Start Date
2018-08-15
Completion Date
2024-06-30
Last Updated
2026-08-11
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Levetiracetam
Anticonvulsant drug
DRUG
Placebo
Placebo
Locations (1)
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, United States